Mathews Journal of Surgery


Previous Issues Volume 6, Issue 4 - 2023

Tail Parotid Tumor: Warthin’s Tumor: Managed With Surgical Treatment

Pankaj Goyal1,*, Nirupama Kothari2

1Apollo ENT Hospital, Pal Road, Jodhpur, Rajasthan, India

2Sterling Accuris Diagnostics, Saras Dairy Road, Jodhpur, Rajasthan, India

*Corresponding author: Pankaj Goyal, Consultant E.N.T. and Head & Neck surgeon, Apollo E.N.T. Hospital, Jodhpur, Rajasthan, India, ORCID: 0000-0003-4098-7308; E-mail: [email protected].

Received Date: October 10, 2023

Published Date: October 21, 2023

Citation: Goyal P, et al. (2023). Tail Parotid Tumor: Warthin’s Tumor: Managed With Surgical Treatment. Mathews J Surg. 6(4):23.

Copyrights: Goyal P, et al. © (2023).


Warthin's tumor, which accounts for around 2-15% of all parotid tumors, is the most common monomorphic adenoma of the main salivary glands. Adenolymphoma, papillary cystadenoma lymphomatosum, and monomorphic adenoma are some of the words used to characterize it. It is a disease of the salivary glands, a benign cystic tumor with an extensive lymphoid stroma and an epithelial component. This tumor, which is found in the parotid gland, is the second most prevalent benign salivary gland tumor. From a clinical perspective, it looks to be a slow-growing tumor that fluctuates frequently due to its cystic form. Complete excision with broad tumor-free margins is considered as the optimum course of treatment. In this case, a 57-year-old male patient had a warthin's tumor that was treated with a parotidectomy and did not recur after six months of follow-up.

Keywords: Warthin’s Tumor, Salivary Gland, Parotid, Surgical Excision, Parotidectomy.

Creative Commons License

© 2015 Mathews Open Access Journals. All Rights Reserved.

Open Access by Mathews Open Access Journals is licensed under a
Creative Commons Attribution 4.0 International License.
Based On a Work at